GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Voyageur Pharmaceuticals Ltd (TSXV:VM) » Definitions » Asset Impairment Charge

Voyageur Pharmaceuticals (TSXV:VM) Asset Impairment Charge : C$0.00 Mil (TTM As of Feb. 2025)


View and export this data going back to 2012. Start your Free Trial

What is Voyageur Pharmaceuticals Asset Impairment Charge?

Voyageur Pharmaceuticals's Asset Impairment Charge for the three months ended in Feb. 2025 was C$0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Feb. 2025 was C$0.00 Mil.

Voyageur Pharmaceuticals Asset Impairment Charge Historical Data

The historical data trend for Voyageur Pharmaceuticals's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voyageur Pharmaceuticals Asset Impairment Charge Chart

Voyageur Pharmaceuticals Annual Data
Trend Dec15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 - - 0.05 0.01

Voyageur Pharmaceuticals Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Voyageur Pharmaceuticals Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Feb. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Voyageur Pharmaceuticals Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Voyageur Pharmaceuticals's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Voyageur Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Voyageur Pharmaceuticals Ltd (TSXV:VM) » Definitions » Asset Impairment Charge
Comparable Companies
NEOE:CBST TSX:AVCN XCNQ:LEEF TSXV:ROMJ XCNQ:GWAY XCNQ:CXXI XCNQ:VEXT XCNQ:IAN XCNQ:RWB TSX:LABS ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
VYYRF:USA
Address
4103B Center Street NW, Calgary, AB, CAN, T2E 2Y6
Website
https://www.voyageurpharmaceuticals.ca
Voyageur Pharmaceuticals Ltd is engaged in acquiring, exploring, and developing raw materials for pharmaceutical products. The company's products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD, and V-Gas.
Executives
Bradley Craig Willis Director, Senior Officer
Trent Abraham Director
Charles Littlejohn 10% Security Holder

Voyageur Pharmaceuticals Headlines

No Headlines